Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 16 studies | 29% ± 11% | |
| peripheral blood | 14 studies | 40% ± 17% | |
| intestine | 10 studies | 29% ± 13% | |
| kidney | 8 studies | 23% ± 8% | |
| eye | 7 studies | 29% ± 12% | |
| uterus | 5 studies | 30% ± 12% | |
| brain | 5 studies | 32% ± 7% | |
| pancreas | 4 studies | 35% ± 16% | |
| bone marrow | 4 studies | 31% ± 14% | |
| prostate | 4 studies | 21% ± 6% | |
| lymph node | 4 studies | 39% ± 15% | |
| breast | 4 studies | 30% ± 7% | |
| placenta | 3 studies | 32% ± 12% | |
| thymus | 3 studies | 32% ± 10% | |
| liver | 3 studies | 35% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 6386.45 | 1445 / 1445 | 100% | 63.66 | 183 / 183 |
| ovary | 100% | 5578.51 | 180 / 180 | 100% | 70.51 | 430 / 430 |
| prostate | 100% | 5923.03 | 245 / 245 | 100% | 127.81 | 502 / 502 |
| uterus | 100% | 5187.51 | 170 / 170 | 100% | 93.35 | 459 / 459 |
| lung | 100% | 6585.34 | 578 / 578 | 100% | 108.77 | 1154 / 1155 |
| kidney | 100% | 5867.90 | 89 / 89 | 100% | 92.61 | 900 / 901 |
| thymus | 100% | 5045.18 | 653 / 653 | 100% | 122.84 | 604 / 605 |
| breast | 100% | 5863.02 | 459 / 459 | 100% | 103.67 | 1116 / 1118 |
| brain | 100% | 5775.55 | 2637 / 2642 | 100% | 108.47 | 705 / 705 |
| bladder | 100% | 6031.81 | 21 / 21 | 100% | 92.70 | 503 / 504 |
| stomach | 100% | 4454.59 | 359 / 359 | 100% | 53.44 | 285 / 286 |
| adrenal gland | 100% | 5749.76 | 258 / 258 | 100% | 130.01 | 229 / 230 |
| intestine | 100% | 6350.09 | 966 / 966 | 98% | 57.51 | 518 / 527 |
| liver | 99% | 2448.95 | 223 / 226 | 100% | 60.49 | 404 / 406 |
| skin | 100% | 5232.74 | 1808 / 1809 | 97% | 67.68 | 458 / 472 |
| pancreas | 97% | 2076.02 | 318 / 328 | 100% | 97.97 | 178 / 178 |
| adipose | 100% | 6596.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 8392.21 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 95.01 | 29 / 29 |
| spleen | 100% | 5920.93 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 84.77 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 57.44 | 1 / 1 |
| muscle | 100% | 3644.62 | 799 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 5776.11 | 922 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 51.58 | 78 / 80 |
| heart | 96% | 3018.96 | 824 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008283 | Biological process | cell population proliferation |
| GO_0005813 | Cellular component | centrosome |
| GO_0000151 | Cellular component | ubiquitin ligase complex |
| GO_0097431 | Cellular component | mitotic spindle pole |
| GO_1904724 | Cellular component | tertiary granule lumen |
| GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
| GO_0030496 | Cellular component | midbody |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | YPEL5 |
| Protein name | Protein yippee-like 5 |
| Synonyms | CGI-127 |
| Description | FUNCTION: Component of the CTLH E3 ubiquitin-protein ligase complex that selectively accepts ubiquitin from UBE2H and mediates ubiquitination and subsequent proteasomal degradation of the transcription factor HBP1 . Required for normal cell proliferation (By similarity). . |
| Accessions | ENST00000402003.7 ENST00000261353.9 P62699 ENST00000379520.7 ENST00000402708.5 ENST00000379519.7 |